Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, The John Arbuthnott Building, 27 Taylor Street, Glasgow G4 0NR, UK.
Drug and Alcohol Research Unit, School of Social Science and Social Work, Plymouth University, 9 Portland Villas, Plymouth, Devon PL4 8AA, UK.
Res Social Adm Pharm. 2014 May-Jun;10(3):576-87. doi: 10.1016/j.sapharm.2013.07.006. Epub 2013 Sep 7.
Internationally, community pharmacies have become increasingly involved in providing harm reduction services and health advice to people who use illicit drugs.
This paper considers public opinion of community pharmacy services. It discusses attitudes to harm reduction services in the context of stigmatization of addiction and people who use drugs.
This exploratory study involved twenty-six purposively sampled members of the public, from the West of Scotland, participating in one of 5 focus groups. The groups were composed to represent known groups of users and non-users of community pharmacy, none of whom were problem drug users.
Three thematic categories were identified: methadone service users in community pharmacies; attitudes to harm reduction policies; contested space. Harm reduction service expansion has resulted in a high volume of drug users in and around some Scottish pharmacies. Even if harm reduction services are provided discretely users' behavior can differentiate them from other pharmacy users. Drug users' behavior in this setting is commonly perceived to be unacceptable and can deter other consumers from using pharmacy services. The results of this study infer that negative public opinion is highly suggestive of stereotyping and stigmatization of people who use drugs. Participants considered that (1) community pharmacies were unsuitable environments for harm reduction service provision, as they are used by older people and those with children; (2) current drug policy is perceived as ineffective, as abstinence is seldom achieved and methadone was reported to be re-sold; (3) people who use drugs were avoided where possible in community pharmacies.
Community pharmacy harm reduction services increasingly bring together the public and drug users. Study participants were reluctant to share pharmacy facilities with drug users. This paper concludes by suggesting mechanisms to minimize stigmatization.
在国际上，社区药房越来越多地参与为滥用非法药物的人提供减少伤害服务和健康建议。
本文考虑了公众对社区药房服务的看法。它讨论了在成瘾和吸毒者污名化的背景下对减少伤害服务的态度。
这项探索性研究涉及来自苏格兰西部的 26 名有目的抽样的公众，他们参加了 5 个焦点小组中的一个。这些小组是由已知的社区药房使用者和非使用者组成的，他们都不是有问题的药物使用者。
确定了三个主题类别：社区药房中的美沙酮服务使用者；对减少伤害政策的态度；有争议的空间。减少伤害服务的扩展导致苏格兰一些药房内和周围有大量的药物使用者。即使提供了减少伤害服务，使用者的行为也可以将他们与其他药房使用者区分开来。在这种环境下，药物使用者的行为通常被认为是不可接受的，可能会阻止其他消费者使用药房服务。这项研究的结果推断，负面的公众意见高度暗示了对吸毒者的刻板印象和污名化。参与者认为：（1）社区药房不适合提供减少伤害服务，因为它们被老年人和有孩子的人使用；（2）目前的毒品政策被认为是无效的，因为很少有人能达到戒毒的目标，而且美沙酮据说被转售；（3）在社区药房，尽可能避免与药物使用者接触。
社区药房的减少伤害服务越来越多地将公众和药物使用者聚集在一起。研究参与者不愿意与药物使用者共享药房设施。本文最后提出了一些机制来最小化污名化。
